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Placental mitochondrial DNA 
and CYP1A1 gene methylation as molecular 
signatures for tobacco smoke exposure 
in pregnant women and the relevance for birth 
weight
Bram G. Janssen1, Wilfried Gyselaers2,3, Hyang‑Min Byun4, Harry A. Roels1,5, Ann Cuypers1, Andrea A. Baccarelli4,6 
and Tim S. Nawrot1,7,8*
Abstract 
Background: Maternal smoking during pregnancy results in an increased risk of low birth weight through pertur‑
bations in the utero‑placental exchange. Epigenetics and mitochondrial function in fetal tissues might be molecular 
signatures responsive to in utero tobacco smoke exposure.
Methods: In the framework of the ENVIRONAGE birth cohort, we investigated the effect of self‑reported tobacco 
smoke exposure during pregnancy on birth weight and the relation with placental tissue markers such as, (1) relative 
mitochondrial DNA (mtDNA) content as determined by real‑time quantitative PCR, (2) DNA methylation of specific 
loci of mtDNA (D-loop and MT-RNR1), and (3) DNA methylation of the biotransformation gene CYP1A1 (the last two 
determined by bisulfite‑pyrosequencing). The total pregnant mother sample included 255 non‑smokers, 65 former‑
smokers who had quit smoking before pregnancy, and 62 smokers who continued smoking during pregnancy.
Results: Smokers delivered newborns with a birth weight on average 208 g lower [95% confidence interval (CI) −318 
to −99, p = 0.0002] than mothers who did not smoke during pregnancy. In the smoker group, the relative mtDNA 
content was lower (−21.6%, 95% CI −35.4 to −4.9%, p = 0.01) than in the non‑smoker group; whereas, absolute 
mtDNA methylation levels of MT-RNR1 were higher (+0.62%, 95% CI 0.21 to 1.02%, p = 0.003). Lower CpG‑specific 
methylation of CYP1A1 in placental tissue (−4.57%, 95% CI −7.15 to −1.98%, p < 0.0001) were observed in smokers 
compared with non‑smokers. Nevertheless, no mediation of CYP1A1 methylation nor any other investigated molecu‑
lar signature was observed for the association between tobacco smoke exposure and birth weight.
Conclusions: mtDNA content, methylation of specific loci of mtDNA, and CYP1A1 methylation in placental tissue 
may serve as molecular signatures for the association between gestational tobacco smoke exposure and low birth 
weight.
Keywords: Birth weight, CYP1A1, Epigenetics, DNA methylation, Mitochondrial DNA content, Mitochondrial DNA 
methylation, Placental tissue, Tobacco smoke
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Background
A growing area of research interest with major public 
health implications are the consequence of insults during 
fetal life for the health status in child- and adulthood. It 
is well known that maternal smoking during pregnancy 
increases the risk of low birth weight [1, 2] and preterm 
delivery [3, 4] which is probably due to perturbations in 
the fetoplacental exchange [5]. The exact mechanism(s) 
underlying these adverse effects remain unclear, but 
emerging data suggests that biochemical, genetic, and 
epigenetic processes respond to and/or are modified by 
in utero tobacco exposure of the fetal organism.
Tobacco smoke consists of particulate and gaseous 
phases containing more than 7000 chemicals of which at 
least 70 substances are known to cause cancer [6]. Con-
stituents of tobacco smoke such as polycyclic aromatic 
hydrocarbons (PAHs) enter cells and may activate genes 
involved in detoxification processes such as CYP1A1 
(cytochrome P450, family 1, subfamily A, polypep-
tide 1) via the aryl hyrdrocarbon  receptor (Ahr) signal-
ing pathway resulting in an oxidative imbalance of the 
cells. Mitochondrial DNA (mtDNA), which resides as 
multiple double stranded circular copies in mitochon-
dria, is extremely vulnerable and responsive to tobacco-
induced oxidative stress [7–9]. As a result, alterations in 
mtDNA content, characterized as increasing or decreas-
ing mtDNA copies, are an indication of dysfunctional or 
damaged mitochondria [10]. The inter-genomic cross-
talk between mitochondria and the nucleus is com-
plex. Growing evidence suggests that mitochondrial 
dysfunction may affect the epigenetic landscape of the 
nuclear genome [11, 12]. DNA methylation is the most 
intensively studied epigenetic modification. Exposures 
to adverse environmental factors are important deter-
minants for methylation programming during early life 
[13, 14]. Global [15–18] and gene-specific (e.g. CYP1A1) 
[19–26] DNA methylation differences have been dem-
onstrated in cord blood and placental cells of neonates 
from mothers who smoked during pregnancy. Disruption 
of the fetal methylome has been associated with adverse 
pregnancy outcomes and could provide an underlying 
mechanism through which smoking affects fetal growth 
[20, 24, 27].
While several studies described separately the effect 
of maternal smoking during pregnancy on birth weight, 
mitochondrial DNA, and CYP1A1 methylation, we inte-
grated these biological endpoints in our investigation of 
placental tissue collected in the framework of the ENVI-
RONAGE birth cohort study [28]. We hypothesized that 
exposure to tobacco smoke during pregnancy impacts 
birth weight and concomitantly also these molecular 
signatures.
Methods
Study population
In the present study, 382 mother-newborn pairs were 
enrolled in the ENVIRONAGE birth cohort in Belgium 
(acronym for ENVIRonmental influence ON AGEing in 
early life). All procedures were approved by the Ethical 
Committee of Hasselt University and East-Limburg Hos-
pital. The study design and procedures were previously 
described in detail [29]. Briefly, written informed consent 
was obtained from each participating mother who gave 
birth in the East-Limburg Hospital in Genk, Belgium. For 
this study, the only inclusion criterion was that mothers 
had to be able to fill out questionnaires in Dutch. Enrol-
ment was equally spread over all seasons of the year. 
Questionnaires and medical records were consulted after 
birth and provided information on maternal age, mater-
nal education, smoking status, ethnicity, pre-pregnancy 
body mass index (BMI), gestational age, newborn’s sex, 
Apgar scores, birth weight and length, parity, and ultra-
sonographic data. Maternal education was coded as “low” 
(no diploma or primary school), “middle” (high school) 
or “high” (college or university degree). Based on the 
native country of the newborn’s grandparents we classi-
fied his/her ethnicity as European-Caucasian when two 
or more grandparents were European, or non-European 
when at least three grandparents were of non-European 
origin. We asked the mothers whether they consumed 
alcohol during pregnancy, used medication, and how 
many times per week they practiced physical exercises 
for at least 20  min. Information about tobacco smoke 
exposure was collected by self-report of the mothers. 
They were asked whether they continued smoking during 
pregnancy (smoker group, n = 62), whether they smoked 
before pregnancy and stopped when pregnant (past-
smoker group, n  =  65), or whether they never smoked 
in their life (non-smoker group, n = 255). Mothers who 
had ever smoked filled out the number of smoking years 
and the number of cigarettes smoked per day before and 
during pregnancy. We also asked the mothers how long 
(months) they continued smoking before becoming 
aware of being pregnant. Furthermore, we have data on 
passive smoke exposure (due to indoor smoking by some-
body else).
Sample collection
Placentas were deep-frozen within 10 min after delivery. 
Specimens of placental tissue were taken on minimally 
thawed placentas for DNA extraction. We took villous 
tissue (1–2  cm3) at a fixed location from the fetal side 
of the placenta, approximately 1–1.5 cm below the cho-
rio-amniotic membrane, and preserved the biopsies at 
−80 °C [30]. At a later stage, genomic DNA was isolated 
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from the placental biopsies using the QIAamp DNA 
mini kit (Qiagen, Inc., Venlo, Netherlands) and stored at 
−80 °C until further use.
DNA methylation analysis
We performed DNA methylation analysis by highly quan-
titative bisulfite polymerase chain reaction (PCR) pyrose-
quencing as previously described in detail [30]. Bisulfite 
conversions were performed using 1  µg of extracted 
genomic DNA with the EZ-96 DNA methylation Gold 
kit (Zymo Research, Orange, CA, USA) according to the 
manufacturer’s instructions. We examined four CpG 
sites within the promoter region of the CYP1A1 gene 
and for the mitochondrial genome we examined two 
CpG sites in the MT-RNR1 region, and three CpG sites 
in the D-loop region. Detailed information regarding 
primer sequences is given in Additional file  1: Table S1. 
Prior to pyrosequencing, PCR amplification of regions 
of interest was performed in a total reaction volume of 
30  µl, containing 15  µl GoTaq Hot Start Green Master 
Mix (Promega, Madison, WI, USA), 10  pmol forward 
primer, 10  pmol reverse primer, 1  µl bisulfite-treated 
genomic DNA, and water. PCR products were puri-
fied and sequenced by pyrosequencing using the Pyro-
Mark Q96 MD Pyrosequencing System (Qiagen, Inc., 
Germantown, MD, USA). The degree of methylation 
was expressed as the ratio (percentage) of methylated 
cytosines over the sum of methylated and unmethylated 
cytosines. The efficiency of the bisulfite-conversion pro-
cess was assessed using non-CpG cytosine residues within 
the sequence. We used 0% (PSQ-T oligo: 5′-TTGC-
GATAC A AC G G GA AC A A AC GT TGA AT TC-3 ′ ) 
and 100% (PSQ-C oligo: 5′-TTGCGATACGACGG-
GAACAAACGTTGAATTC-3′) DNA methylation con-
trol oligos. The sequencing primer for the control oligo 
was: 5′-AACGTTTGTTCCCGT-3′. We mixed the PSQ-C 
oligo (or PSQ-T oligo) with the sequencing oligo in Pyro-
Mark Annealing Buffer (Qiagen, Inc., Valencia, CA, USA) 
and performed pyrosequencing with the sequencing entry 
C/TGTAT. We assessed the within-placenta variability in 
a random subset of 19 placentas as previously described 
[30]. The between-placenta variability was higher than 
the within-placenta variability for CYP1A1 (58 vs. 42%, 
p < 0.0001), the D-loop region (61 vs. 39%, p = 0.01), and 
MT-RNR1 (58 vs. 42%, p = 0.009).
Mitochondrial DNA content analysis
The mtDNA content was measured by determin-
ing the ratio of two mitochondrial gene copy numbers 
(MTF3212/R3319 and MT-ND1) to two single-copy 
nuclear control genes (RPLP0 and ACTB) using a quan-
titative real-time PCR (qPCR) assay as previously 
described [29] and used with a small modification. 
Isolated genomic DNA (12.5 ng) was added to 7.5 µl mas-
termix consisting of Fast SYBR® Green I dye 2x (5  µl/
reaction), forward and reverse primer (each 0.3 µl/reac-
tion), and RNase free water (1.9  µl/reaction) for a final 
volume of 10  µl per well. Primer sequences (Additional 
file  1: Table S1) were diluted to a final concentration of 
300  nM in the master mix. Samples were run in tripli-
cate in a 384-well format. Real-time PCR was performed 
using the 7900HT Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA) with the following 
thermal cycling profile: 20  s at 95  °C (activation), fol-
lowed by 40 cycles of 1 s at 95 °C (denaturation) and 20 s 
at 60  °C (annealing/extension), and ending with melting 
curve analysis (15 s at 95 °C, 15 s at 60 °C, 15 s at 95 °C). 
qBase software (Biogazelle, Zwijnaarde, Belgium) was 
used to normalize data and correct for run-to-run differ-
ences [31].
Statistical analysis
We used SAS software (version 9.2; SAS Institute Inc., 
Cary, NC, USA) for database management and statistical 
analysis. Relative mtDNA content (unitless) was log10-
transformed to normalize the distribution. The relation-
ships between smoking and continuous variables were 
examined with one-way ANOVA procedures and Chi 
square tests for the categorical variables. We applied 
conventional multiple linear regression to estimate the 
association between maternal smoking status and birth 
weight, length, or placental mtDNA content. The pyrose-
quencing-based DNA methylation analysis produced 
a methylation value (%) for each CpG site of CYP1A1 
(four CpGs), MT-RNR1 (two CpGs) and the D-loop 
region (three CpGs). Correlations between adjacent CpG 
sites within one gene or region were tested with Pear-
son correlation coefficients. With mixed-effects models, 
we took into account each CpG dinucleotide position 
and tested the association between gene-specific DNA 
methylation and maternal smoking status. We applied 
Dunnett’s test for multiple comparisons of smokers and 
past-smokers with the reference group (non-smokers). 
Maternal alcohol consumption, medication use, physi-
cal activity, maternal education, ethnicity, maternal age, 
pre-pregnancy BMI, parity, gestational age, and new-
born’s sex were considered as possible confounders, but 
only those associated with maternal smoking (p ≤ 0.05) 
and which potentially could influence birth weight and 
length, mtDNA content or DNA methylation were con-
sidered for entry in the models. However, newborn’s sex, 
maternal age, gestational age, ethnicity, parity, and pre-
pregnancy BMI were forced into the model regardless of 
the p value, in addition to maternal education, and alco-
hol consumption. Q–Q plots of the residuals were used 
to test the linearity assumption of the models.
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In a sensitivity analysis, Pearson correlation coeffi-
cients were calculated between birth weight or length 
and measures of smoking (years of smoking, pack-year or 
number of cigarettes smoked per day during pregnancy). 
Furthermore, we used mediation analysis to investigate 
whether the examined molecular signatures underlie the 
association between gestational tobacco smoke exposure 
and birth weight [32].
Results
Participant’s demographics and lifestyle factors
Demographic characteristics and perinatal factors of 382 
mother-newborn pairs are reported in Table 1. The new-
borns, among them 194 girls (50.8%), had a mean ges-
tational age of 39.2  weeks (range 35–42) and comprised 
200 (52.3%) primiparous and 142 (37.2%) secundipa-
rous newborns. The mean (SD) birth weight of the new-
borns was 3429 (426) g and birth length 50.3 (1.9) cm. 
About 90% (n  =  332) of the newborns were Europeans 
of Caucasian ethnicity. Mean maternal age was 29.0 years 
(range 18–42  years). Most women (66.7%, n  =  255) 
never smoked cigarettes and 65 women (17.0%) stopped 
smoking before pregnancy; whereas, 62 mothers (16.2%) 
reported to have smoked during pregnancy [on average 
7.8 cigarettes per day (inter quartile range, IQR: 5–10]. A 
fair number of mothers (n = 73, 19.1%) occasionally con-
sumed alcohol during their pregnancy.
Compared to the non-smokers, the group of smoking 
mothers were younger (27.7 ±  4.8 vs. 29.0  years ±  4.7, 
p = 0.008), comprised less women with higher education 
(22.6 vs. 59.6%, p  <  0.0001), and delivered newborns of 
lower birth weight and length. Alcohol consumption was 
higher in the past-smoker group than in the non-smoker 
group (30.8 vs. 16.5%, p = 0.01).
Smoking status and birth parameters
Birth weight and length were respectively 225 g and 1 cm 
lower for newborns from the smoker mothers compared to 
the non-smokers (Table 1). After adjustment for maternal 
age, gestational age, newborn’s sex, maternal education, 
ethnicity, parity, pre-pregnancy BMI, and alcohol con-
sumption, we still observed a lower birth weight (−208 g, 
95% CI −318 to −99  g, p =  0.0002) and a shorter birth 
length (−1.0 cm, 95% CI −1.5 to −0.5 cm, p < 0.0001) in 
newborns delivered by women who continued smoking 
during pregnancy compared to non-smoking mothers. 
Mothers who stopped smoking before pregnancy deliv-
ered newborns whose birth weight (p  =  0.55) or length 
(p = 0.87) did not differ from that of never-smokers.
Smoking status and mtDNA in placental tissue
After adjustment for the aforementioned covariates, the 
relative mtDNA content in placental tissue was 21.6% (95% 
CI −35.4 to −4.9, p =  0.01) lower in smoking mothers, 
but not in past-smokers (p  =  0.72), in comparison with 
non-smokers (Fig.  1). In contrast, absolute methylation 
levels of the mitochondrial genome at the MT-RNR1 gene 
were higher in mothers who continued smoking during 
pregnancy (+0.62%, 95% CI 0.21 to 1.02, p = 0.003) and 
marginally higher in mothers who stopped smoking prior 
to pregnancy (+0.37%, 95% CI −0.02 to 0.75, p  =  0.06) 
compared with non-smokers (Fig. 1). We found no inter-
action between smoking status and CpG site of MT-RNR1 
(pint  =  0.94), and the methylation levels at the D-loop 
region did not differ between the groups (p = 0.85).
Smoking status and gene‑specific CYP1A1 methylation 
in placental tissue
The examined CpGs in the promoter region of CYP1A1 
showed strong inter-correlations for placental tissue 
(r = 0.71–0.93, p < 0.0001) (Additional file 1: Figure S1). 
Unadjusted mixed-effects models revealed an interac-
tion effect between smoking status and CpG sites of 
the promoter region of CYP1A1 (pint  <  0.0001). Placen-
tal methylation levels at CpG3 were significantly lower 
in mothers who continued smoking during pregnancy 
compared to non-smoking mothers (Fig.  2), even after 
adjustment for maternal age, gestational age, newborn’s 
sex, maternal education, ethnicity, parity, pre-pregnancy 
BMI, and alcohol consumption (−4.57%, 95% CI −7.15 
to −1.98, p < 0.0001) (Table 2). No significant differences 
in CpG methylation levels were observed in mothers who 
stopped smoking before pregnancy. 
Sensitivity analysis
As anticipated, we observed a clear dose-effect relation 
between birth weight or length and measures of smok-
ing status (years of smoking, pack-year, or the num-
ber of cigarettes smoked per day during pregnancy). In 
comparison with non-smokers, no significant difference 
was observed in birth weight or length of newborns 
from mothers who stopped smoking for a longer period 
of time before pregnancy or mothers who stopped just 
prior to pregnancy. We observed a positive association 
of CYP1A1 methylation levels with placental mtDNA 
content (r = 0.14, p = 0.005), and a negative association 
with placental mtDNA methylation (r = −0.11, p = 0.02) 
(Fig.  3). Furthermore, we observed no mediation of 
CYP1A1 methylation nor any other investigated molecu-
lar signature between the association of tobacco smoke 
exposure and birth weight (data not shown).
Discussion
The present investigation showed that women who 
smoked during pregnancy had neonates with lower 
birth weight and length, lower mtDNA content, higher 
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mtDNA methylation at specific loci, and lower CpG-spe-
cific methylation levels of CYP1A1 in placental tissue.
Despite a limited number of (epi)genomic studies in 
placental tissue and cord blood, we are improving our 
understanding of the molecular pathways underlying the 
association between gestational tobacco smoke expo-
sure and low birth weight. Combining gene expression 
and epigenome-wide methylation arrays Suter et al. [26] 
showed that the expression of 623 genes and the methyla-
tion of 1024 CpG dinucleotides were significantly altered 
in placentas of smokers. For 438 genes significant cor-
relations were revealed between methylation and gene 
expression, and their potential functions or mechanisms 
were explored using an Ingenuity Pathway Analysis. The 
authors found that the gene list was enriched for genes 
involved in functional pathways such as mitochondrial 
dysfunction, oxidative phosphorylation and hypoxia. 
Indeed, mitochondria, the “powerhouses” of cells, pro-
vide cellular energy via oxidative phosphorylation and 
are very sensitive to exposures that induce oxidative 
stress. The double stranded circular mtDNA, of which 
multiple copies are present in mitochondria, is vulner-
able to reactive oxygen species (ROS) because of an inef-
ficient DNA repair capacity and close proximity to the 
Table 1 Characteristics of mother-newborn pairs according to self-reported tobacco smoke exposure during pregnancy
Data are presented as arithmetic mean ± standard deviation (SD) or number (%)
* p value derived from one-way ANOVA or Chi square tests in case of continuous or categorical variables respectively
a Medication use: occasional use of paracetamol or antibiotics (28 missing data)
b Missing data for 15 subjects
Variable All
(n = 382)
Non‑smokers
(n = 255)
Past‑smokers
(n = 65)
Smokers
(n = 62)
p value*
Newborn
 Sex 0.47
  Male 188 (49.2%) 120 (47.1%) 34 (52.3%) 34 (54.8%)
  Female 194 (50.8%) 135 (52.9%) 31 (47.7%) 28 (45.2%)
 Ethnicity 0.73
  European‑Caucasian 332 (86.9%) 223 (87.4%) 57 (87.7%) 52 (83.9%)
  Non‑European 50 (13.1%) 32 (12.6%) 8 (12.3%) 10 (16.1%)
 Gestational age, w 39.2 ± 1.2 39.3 ± 1.2 39.2 ± 1.3 39.2 ± 1.2 0.82
 Birth weight, g 3429 ± 426 3472 ± 424 3437 ± 423 3247 ± 395 0.0009
 Birth length, cm 50.3 ± 1.9 50.5 ± 2.0 50.5 ± 1.7 49.5 ± 1.8 0.0007
Mother
 Age, year 29.0 ± 4.7 29.4 ± 4.5 28.9 ± 4.9 27.7 ± 4.8 0.03
 Pre‑pregnancy BMI, kg/m2 24.3 ± 4.5 24.2 ± 4.4 24.8 ± 5.3 24.2 ± 4.1 0.65
 Maternal education <0.0001
  Low 51 (13.3%) 26 (10.2%) 6 (9.2%) 19 (30.6%)
  Middle 131 (34.3%) 77 (30.2%) 25 (38.5%) 29 (46.8%)
  High 200 (52.4%) 152 (59.6%) 34 (52.3%) 14 (22.6%)
 Medication usea 0.57
  None 134 (37.8%) 92 (39.5%) 21 (32.3%) 21 (37.5%)
 Alcohol consumption 0.03
  Occasionally 73 (19.1%) 42 (16.5%) 20 (30.8%) 11 (17.7%)
 Physical activity (>20 min)b 0.40
  <1 times per week 122 (33.3%) 82 (33.3%) 19 (29.7%) 21 (36.8%)
  1 times per week 86 (23.4%) 63 (25.6%) 15 (23.4%) 8 (14.0%)
  >2 times per week 159 (43.3%) 101 (41.1%) 30 (46.9%) 28 (49.2%)
 Parity 0.42
  1 200 (52.3%) 132 (51.8%) 36 (55.4%) 32 (51.6%)
  2 142 (37.2%) 91 (35.7%) 25 (38.5%) 26 (41.9%)
  ≥3 40 (10.5%) 32 (12.5%) 4 (6.1%) 4 (6.5%)
 Cigarettes before pregnancy – – 11.0 ± 6.9 10.3 ± 6.7
 Cigarettes during pregnancy – – – 7.8 ± 4.6
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electron transport chain [33]. The estimated mutation 
rate of mtDNA is 5-10 times higher compared to nuclear 
DNA [34]. We showed that placental mtDNA content 
and methylation levels were responsive to tobacco smoke 
exposure during pregnancy indicating that mtDNA is a 
sensitive marker of mitochondrial damage and dysfunc-
tion as proposed by Sahin et al. [10]. In addition to other 
studies reporting changes in placental mtDNA content in 
smoking mothers [7, 8] or mothers exposed to air pollu-
tion [29], we provide here the first epidemiological evi-
dence of altered methylation levels at specific loci of the 
mitochondrial genome of placental tissue in response to 
tobacco smoke exposure during pregnancy. We suggest 
that pollution-induced epigenetic modifications of the 
mitochondrial genome may prime alterations in mtDNA 
content by regulating mitochondrial function and bio-
genesis [35]. Damaged or non-functioning mitochondria 
are specifically degraded through mitophagy and could 
result in a depletion of mtDNA [36], which moreover 
may lead to changes in methylation patterns of a num-
ber of nuclear genes [12]. The sensitivity analysis showed 
that mtDNA content and mtDNA methylation correlated 
with methylation of CYP1A1 in placental tissue, which 
could be indicative of a relationship between mitochon-
drial dysfunction and the epigenetic landscape of the 
nuclear genome [11]. Whether mitochondrial dysfunc-
tion affects gene expression and methylation patterns of 
other genes needs to be elucidated.
An expanding body of evidence suggests that the epi-
genome of placental tissue and cord blood is sensitive to 
environmental exposures [13]. Epigenome-wide methyla-
tion studies are used to examine the epigenetic status of 
the human genome at many different loci in a number of 
individuals and also to assess whether any of these CpG 
loci are associated with a trait or an environmental pol-
lutant [37]. A 450 K epigenome-wide methylation study 
by Joubert et  al. [23] demonstrated differentially meth-
ylated detoxifying genes (AHRR and CYP1A1) in cord 
blood of newborns exposed to tobacco smoke during 
pregnancy. This finding was confirmed in another popu-
lation of infants by analyzing whole blood obtained by 
a heel prick [25]. Maternal smoking as assessed by both 
self-report and cotinine levels in plasma showed higher 
methylation levels at different CpGs of CYP1A1 in cord 
blood [23]. Conversely, in placental tissue of smoker 
mothers, Suter et al. [19] observed hypomethylated CpG 
dinucleotides proximal to a xenobiotic response element 
(XRE); whereas, those distal from such elements did not 
demonstrate differential methylation. The authors cal-
culated the total percentage of methylation for a distinct 
region of the promoter (−1411 to −1295  bp from the 
transcription start site) without taking into account the 
separate CpGs, unlike we did in our study. We observed 
lower methylation levels at a specific CpG site that lies 
adjacent to a XRE site in placental tissue of mothers who 
smoked during pregnancy. It is important to note that 
Fig. 1 Estimated mean levels of mtDNA content and mtDNA 
methylation in placental tissue of non‑smokers (n = 255), past smok‑
ers (n = 65), and current smokers (n = 62). The bars represent the 
estimated means with 95% confidence intervals for the non‑smoking 
(filled circle), past‑smoking (filled square), and smoking group (filled 
triangle). a Relative mtDNA content levels (unitless) are log10‑trans‑
formed; b Methylation of the MT‑RNR1 gene are absolute methyla‑
tion levels. Both the generalized linear model for mtDNA content 
and the mixed‑effects model for mtDNA methylation were adjusted 
for maternal age, gestational age, newborn’s sex, maternal educa‑
tion, ethnicity, parity, pre‑pregnancy BMI, and alcohol consumption. 
(*)p = 0.06; *p < 0.05; **p < 0.005: difference compared to the non‑
smoking group
Fig. 2 Unadjusted estimates of methylation levels in percentage 
(%) at four targeted CpG sites within the CYP1A1 promoter region of 
placental tissue. Estimated methylation levels at each CpG are indi‑
cated for each smoking category [black non‑smokers (n = 255); grey 
past‑smokers (n = 65); red smokers (n = 62)]. The error bars display 
the 95% confidence intervals
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this specific CpG site harbors a C/G single nucleotide 
polymorphism (SNP: rs3809585 with allele frequencies 
C: 1.717% and G: 98.283%). We are confident that this 
SNP did not affect DNA methylation since all pyrograms 
confirmed a G nucleotide in the analyzed sequence. 
Interestingly, the study of Joubert et  al. [23] in cord 
blood, the study of Suter et al. [19] in placental tissue, and 
our study in placental tissue, examined approximately 
the same region of interest and CpGs, however with 
different detection methods (Fig.  4). With the bisulfite 
pyrosequencing approach, we confirmed hypomethyla-
tion at a  specific CpG of the CYP1A1 gene in placental 
tissue which is in contrast with the findings in cord blood 
[23]. Although we lacked meaningful gene expression 
data of CYP1A1 in our study, Suter et al. [19] previously 
showed that lower methylation levels in a region cover-
ing the XRE site were correlated with increased expres-
sion of CYP1A1 in placental tissue. Moreover, other 
studies demonstrated increased CYP1A1 mRNA [38] and 
protein [39] expression in human placentas in response 
to tobacco smoke exposure. Constituents of tobacco 
smoke such as PAHs enter cells and are recognized by the 
aryl hydrocarbon receptor (Ahr) causing its translocation 
to the nucleus and the formation of a heterodimer with 
the Ahr nuclear translocator protein (ARNT). This com-
plex binds to genes with a XRE within the promoter and 
initiates expression of detoxifying enzymes involved in 
phase I and II xenobiotic metabolism [40].
A limitation of our study is the chance of exposure 
misclassification. Information about maternal smok-
ing during pregnancy was based on self-report and is 
not verifiable. A possibility to overcome this limitation 
is the determination of the cotinine concentration in 
plasma or urine of the mother. Nevertheless, previous 
studies demonstrated that this would not be superior to 
self-reported smoking habit in pregnant women [2]. We 
acknowledge the fact that we cannot fully exclude resid-
ual or unmeasured confounding by other factors that 
Table 2 Effect of tobacco smoking status during pregnancy on CpG sites of CYP1A1 in placental tissue (n = 382)
Data shown in italic is significant
Mixed-effects models are adjusted for maternal age, gestational age, newborn’s sex, maternal education, ethnicity, parity, pre-pregnancy BMI, and alcohol 
consumption
a Estimated absolute percentage (%) change in methylation levels for each CpG of CYP1A1 compared to the non-smoking group (reference). The 95% CI and p values 
are adjusted according to Dunnett’s procedure
CYP1A1 methylationa Non‑smoking Past‑smoking Smoking
% (95% CI) p value % (95% CI) p value
CpG 1 Ref. −1.16 (−5.90 to 3.56) 0.99 1.75 (−3.09 to 6.60) 0.95
CpG 2 Ref. −0.30 (−4.25 to 3.66) 0.99 0.43 (−3.63 to 4.49) 0.99
CpG 3 Ref. 0.02 (−2.47 to 2.51) 0.99 −4.57 (−7.15 to −1.98) <0.0001
CpG 4 Ref. 1.00 (−2.11 to 4.11) 0.98 0.98 (−2.22 to 4.19) 0.99
Fig. 3 Correlation between CYP1A1 methylation levels (%) and mtDNA content (log10) or mtDNA methylation (MT-RNR1) (%) in placental tissue. The 
dashed lines in the correlation plots depict the 95% CI
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could be associated with both tobacco smoke exposure 
and placental molecular signatures. Although a causal 
relationship exists between prenatal tobacco smoke 
exposure and low birth weight or preterm birth, not all 
infants exposed to tobacco smoke develop these adverse 
perinatal outcomes. It is therefore reasonable to assume 
that several interactions exists between tobacco smoke 
exposure and biochemical, genetic, and epigenetic fac-
tors which make the fetus more susceptible to changes in 
fetal programming.
Our findings are of clinical relevance because 
responses of mitochondrial DNA and changes in the fetal 
methylome are plausible alterations that may underlie 
the adverse effect of tobacco smoke exposure on birth 
weight. They increase our knowledge on the mechanisms 
of perturbations in the fetoplacental exchange that might 
lie at basis of low birth weight and, hence, may be used in 
the broader sense of clinical context.
Conclusions
This study provides epidemiological evidence of molecu-
lar changes in placental tissue that can serve as molecular 
signatures of exposure to tobacco smoke during preg-
nancy. Whether the molecular signatures described in 
our study may be related to early developmental changes 
in Belgian children will be investigated in the ongoing 
follow-up study of the ENVIRONAGE birth cohort.
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